Winton Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BIT
BG
Winton Capital Management's BSX Position: Q1 2014 in Review
Winton Capital Management increased its Boston Scientific (BSX) stake by 327% in Q1 2014, buying an estimated $15M and bringing the position to 1,493,017 shares worth $20.2M. The position accounts for 0.14% of the portfolio, ranked #262.
Winton Capital Management first reported a position in BSX in Q2 2013 and has held it in 4 quarters since. 440 funds tracked by Wall St. Rank hold BSX as of Q1 2014.
- Winton Capital Management held 1,493,017 shares of Boston Scientific worth $20.2M as of Q1 2014.
- Winton Capital Management bought 1,143,050 Boston Scientific shares in Q1 2014, an estimated $15M.
- Boston Scientific made up 0.14% of Winton Capital Management's portfolio in Q1 2014, its #262 holding.
- Winton Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 4 quarters since.
- 440 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2014.
Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.